Thank you for your question regarding CMS506v7 Safe Use of Opioids - Concurrent Prescribing. Clinically equivalent services may be mapped to the codes used in the measure’s value sets to satisfy measure requirements. Unfortunately, we are unable to provide specific guidance related to the mapping of codes. We recommend that you consult with your EHR vendor and clinical partners. If mapping is conducted, you should maintain documentation in case of a CMS audit.

Regarding the Opioid Medication Assisted Treatment (MAT) denominator exclusion for CMS 506, we are seeking clarification if documenting the opioid dependence indication for methadone, buprenorphine, and buprenorphine/naloxone is sufficient for meeting this measure. Context: Our EHR allows for mapping the three SNOMED codes associated with the MAT value set to medication indication documentation. DRUG ADDICTION THERAPY - METHADONE [SNOMED#310653000] DRUG ADDICTION THERAPY USING BUPRENORPHINE [SNOMED#792901003] DRUG ADDICTION THERAPY USING BUPRENORPHINE AND NALOXONE [SNOMED#792902005] Does documentation of the medication indication meet the intent of this measure denominator exclusion? Or should we infer that something beyond documentation of the opioid dependence indication is required by the requirement being labeled "intervention performed"? Thank you!